0 Beoordelingen

ID

14898

Beschrijving

IRESSA™ (Gefitinib) in Breast Cancer Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00632723

Link

https://clinicaltrials.gov/show/NCT00632723

Trefwoorden

  1. 05-05-16 05-05-16 -
  2. 18-06-16 18-06-16 -
  3. 20-09-21 20-09-21 -
Geüploaded op

5 mei 2016

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :


    Geen commentaren

    U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

    Eligibility Breast Cancer NCT00632723

    Eligibility Breast Cancer NCT00632723

    Inclusion Criteria
    Beschrijving

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    histological or cytological confirmation of breast cancer that is either
    Beschrijving

    ID.1

    Datatype

    boolean

    Alias
    UMLS CUI [1]
    C0019638
    a primary tumour in a patient unfit for or who has declined surgery
    Beschrijving

    ID.2

    Datatype

    boolean

    Alias
    UMLS CUI [1,1]
    C0677930
    UMLS CUI [1,2]
    C0677930|C0749186
    advanced (locally or metastatic) disease
    Beschrijving

    ID.3

    Datatype

    boolean

    Alias
    UMLS CUI [1]
    C0679246
    acquired resistance to tamoxifen or er negative tumour
    Beschrijving

    ID.4

    Datatype

    boolean

    Alias
    UMLS CUI [1,1]
    C0332325
    UMLS CUI [1,2]
    C0039286|C2584629
    at least one measurable or assessable lesion
    Beschrijving

    ID.5

    Datatype

    boolean

    Alias
    UMLS CUI [1]
    C1513041
    who performance status 0 - 2
    Beschrijving

    ID.6

    Datatype

    boolean

    Alias
    UMLS CUI [1]
    C1520224
    life expectancy of 12 weeks or more
    Beschrijving

    ID.7

    Datatype

    boolean

    Alias
    UMLS CUI [1]
    C0023671
    Exclusion Criteria
    Beschrijving

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    more than one previous chemotherapy regimens for advanced disease
    Beschrijving

    ID.8

    Datatype

    boolean

    Alias
    UMLS CUI [1,1]
    C0205156
    UMLS CUI [1,2]
    C0392920
    prior anthracycline chemotherapy (> 250 mg/m2 adriamycin)
    Beschrijving

    ID.9

    Datatype

    boolean

    Alias
    UMLS CUI [1]
    C0003234
    radiotherapy completed within 14 days prior to day 1 of treatment
    Beschrijving

    ID.10

    Datatype

    boolean

    Alias
    UMLS CUI [1]
    C1522449
    incomplete healing from prior oncologic or other major surgery
    Beschrijving

    ID.11

    Datatype

    boolean

    Alias
    UMLS CUI [1]
    C0543478
    signs of neurological symptoms consistent with spinal cord compression
    Beschrijving

    ID.12

    Datatype

    boolean

    Alias
    UMLS CUI [1,1]
    C0235031
    UMLS CUI [1,2]
    C0037926
    any evidence of clinically active interstitial lung disease (patients with chronic stable
    Beschrijving

    ID.13

    Datatype

    boolean

    Alias
    UMLS CUI [1]
    C0206062

    Similar models

    Eligibility Breast Cancer NCT00632723

    Name
    Type
    Description | Question | Decode (Coded Value)
    Datatype
    Alias
    Item Group
    C1512693 (UMLS CUI)
    ID.1
    Item
    histological or cytological confirmation of breast cancer that is either
    boolean
    C0019638 (UMLS CUI [1])
    ID.2
    Item
    a primary tumour in a patient unfit for or who has declined surgery
    boolean
    C0677930 (UMLS CUI [1,1])
    C0677930|C0749186 (UMLS CUI [1,2])
    ID.3
    Item
    advanced (locally or metastatic) disease
    boolean
    C0679246 (UMLS CUI [1])
    ID.4
    Item
    acquired resistance to tamoxifen or er negative tumour
    boolean
    C0332325 (UMLS CUI [1,1])
    C0039286|C2584629 (UMLS CUI [1,2])
    ID.5
    Item
    at least one measurable or assessable lesion
    boolean
    C1513041 (UMLS CUI [1])
    ID.6
    Item
    who performance status 0 - 2
    boolean
    C1520224 (UMLS CUI [1])
    ID.7
    Item
    life expectancy of 12 weeks or more
    boolean
    C0023671 (UMLS CUI [1])
    Item Group
    C0680251 (UMLS CUI)
    ID.8
    Item
    more than one previous chemotherapy regimens for advanced disease
    boolean
    C0205156 (UMLS CUI [1,1])
    C0392920 (UMLS CUI [1,2])
    ID.9
    Item
    prior anthracycline chemotherapy (> 250 mg/m2 adriamycin)
    boolean
    C0003234 (UMLS CUI [1])
    ID.10
    Item
    radiotherapy completed within 14 days prior to day 1 of treatment
    boolean
    C1522449 (UMLS CUI [1])
    ID.11
    Item
    incomplete healing from prior oncologic or other major surgery
    boolean
    C0543478 (UMLS CUI [1])
    ID.12
    Item
    signs of neurological symptoms consistent with spinal cord compression
    boolean
    C0235031 (UMLS CUI [1,1])
    C0037926 (UMLS CUI [1,2])
    ID.13
    Item
    any evidence of clinically active interstitial lung disease (patients with chronic stable
    boolean
    C0206062 (UMLS CUI [1])

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial